Effect of titanium dental implants on proton therapy delivered for head tumors: experimental validation using an anthropomorphic head phantom. (27th March 2017)

• Record Type: Journal Article
• Authors: Oancea, C.; Shipulin, K.; Mytsin, G.; Molokanov, A.; Niculae, D.; Ambrožová, I.; Davídková, M.
• Is Part Of: Journal of instrumentation. Volume 12:Number 3(2017:Mar.)
• Page Start: C03082
• Page End: C03082
• Publication Date: 2017-03-27
• Subjects: Dosimetry concepts and apparatus -- Instrumentation for hadron therapy -- Microdosimetry and nanodosimetry -- Particle tracking detectors (Solid-state detectors); Scientific apparatus and instruments -- Periodicals; 502.84
• DOI: 10.1088/1748-0221/12/03/C03082
• Languages: English
• ISSNs: 1748-0221

Abstract

Abstract: A dosimetric experiment was performed at the Medico-Technical Complex in the Joint Institute for Nuclear Research, Dubna, to investigate the effects of metallic dental implants in the treatment of head and neck tumours with proton therapy. The goal of the study was to evaluate the 2D dose distributions of different clinical treatment plans measured in an anthropomorphic phantom, and compare them to predictions from a treatment planning system. The anthropomorphic phantom was sliced into horizontal segments. Two grade 4 Titanium implants were inserted between 2 slices, corresponding to a maxillary area. GafChromic EBT2 films were placed between the segments containing the implants to measure the 2D delivered dose. Two different targets were designed: the first target includes the dental implants in the isocentre, and in the second target, the proton beam is delivered through the implants, which are located at the entrance region of the Bragg curve. The experimental results were compared to the treatment plans made using our custom 3D Treatment Planning System, named RayTreat. To quantitatively determine differences in the isodose distributions (measured and calculated), the gamma index (3 mm, 3%) was calculated for each target for the matrix value in the region of high isodose ( > 90% ): for the experimental setup, which includes the implants in the SOBP region, the result obtained was 84.3%. When the implants were localised in the entrance region of the Bragg curve, the result obtained was 86.4%. In conclusion, the uncertainties introduced by the clinically planned dose distribution are beyond reasonable limits. The linear energy transfer spectra in close proximity to the implants were investigated using solid state nuclear track detectors (TED). Scattered particles outside the target were detected.